[go: up one dir, main page]

PA8175201A1 - ORAL FORMULATIONS OF IBUFRENO S (+) - - Google Patents

ORAL FORMULATIONS OF IBUFRENO S (+) -

Info

Publication number
PA8175201A1
PA8175201A1 PA19968175201A PA8175201A PA8175201A1 PA 8175201 A1 PA8175201 A1 PA 8175201A1 PA 19968175201 A PA19968175201 A PA 19968175201A PA 8175201 A PA8175201 A PA 8175201A PA 8175201 A1 PA8175201 A1 PA 8175201A1
Authority
PA
Panama
Prior art keywords
ibufreno
oral formulations
isobutylphenyl
ibuprofen
propionic acid
Prior art date
Application number
PA19968175201A
Other languages
Spanish (es)
Inventor
Leslie George Humber
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of PA8175201A1 publication Critical patent/PA8175201A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Esta invención revela formulaciones organolépticas aceptables que contienen S(+)-2-(p-isobutilfenil)-ácido propiónico, también conocido como ibuprofeno S(+).This invention reveals acceptable organoleptic formulations containing S (+) - 2- (p-isobutylphenyl) -propionic acid, also known as ibuprofen S (+).

PA19968175201A 1995-06-13 1996-07-08 ORAL FORMULATIONS OF IBUFRENO S (+) - PA8175201A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16995P 1995-06-13 1995-06-13

Publications (1)

Publication Number Publication Date
PA8175201A1 true PA8175201A1 (en) 1998-09-18

Family

ID=40257129

Family Applications (1)

Application Number Title Priority Date Filing Date
PA19968175201A PA8175201A1 (en) 1995-06-13 1996-07-08 ORAL FORMULATIONS OF IBUFRENO S (+) -

Country Status (3)

Country Link
KR (1) KR970000226A (en)
CO (1) CO4700436A1 (en)
PA (1) PA8175201A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100700721B1 (en) * 2000-09-08 2007-03-27 지상철 Purification of S (+)-ibuprofen with improved stability and dissolution rate
KR101004526B1 (en) * 2004-11-09 2010-12-31 주식회사 하이닉스반도체 Capacitor Formation Method of Semiconductor Device

Also Published As

Publication number Publication date
CO4700436A1 (en) 1998-12-29
KR970000226A (en) 1997-01-21

Similar Documents

Publication Publication Date Title
AR002442A1 (en) ORAL FORMULATIONS OF IBUPROFEN S (+)
BR9712491A (en) Cosmetic compositions
AP9901534A0 (en) Pharmaceutical formulations.
BR9917007A (en) Ccr5 modulators
HN1997000072A (en) PROCEDURE FOR THE PREPARATION OF SILDENAFIL
AU1602100A (en) Improved gamma amino butyric acid analogs
IT1278358B1 (en) SOLE FOR FOOTWEAR.
HK1005361A1 (en) Nodulisporic acid derivatives
ZA964928B (en) Oral formulations of S(+)-etodolac.
NO974322D0 (en) DNA encoding human papillomavirus type 18
AU7261996A (en) Angled beam delivery handpiece for laser or other monochromatic light source
AR007165A1 (en) PHARMACEUTICAL COMPOSITION FOR ORAL USE CONTAINING DICLOFENAC.
PA8175201A1 (en) ORAL FORMULATIONS OF IBUFRENO S (+) -
MY127474A (en) Naphthyl compounds, intermediates, compositions, and methods of use
AU7296696A (en) Deodorising formulations containing cationic biopolymers, aluminium chlorhydrate and esterase inhibitors
ZA975755B (en) Useful formulations of acid addition salt drugs.
EP1082967A4 (en) Preventives/remedies for autoimmune demyelinating diseases
BR9712805A (en) Process for the preparation of pharmaceutical compounds
AU9503598A (en) Therapeutically effective 1alpha, 25-dihydroxyvitamin D3 analogs
ZA978406B (en) Nodulisporic acid derivatives.
MX9203486A (en) (QUINOLIN-2-IMETOXI) INDOL AS INHIBITORS OF LEUCOTRENE BIOSYNTHESIS).
KR970049682U (en) Soul plate of the beast for P.C.beam
BR9713998A (en) Use of 17beta-dihydroequilenin as an antioxidant
ITBO930115V0 (en)  HANDPIECE HOLDER TAB FOR PRIMARY INSTRUMENTS.
ES1030257Y (en) DEVICE FOR THE PERFORMED ADVERTISING OF ADVERTISING MESSAGES.